Martinovits G, Melamed E, Cohen O, Rosenthal J, Uzzan A (1986) Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)
In postmenopausal women in Egypt, the prevalence of osteopenia and osteoporosis is 53.9% and 28.4%, respectively
Ben Ameur, S., Aloulou, H., Nasrallah, F., Kamoun, T., Kaabachi, N
Enhances Immune Function With age, immune function declinesa process known as immunosenescence
This conclusion is based on randomized studies with a mean follow-up of 1.74 years (minimum 1 year maximum 3.5 years) and confirmation through TSA that enough patients have been studied so far to exclude this association for this length of time, long-term associations cannot be analysed with the current studies
The study included five cohorts, each receiving 12 once-weekly (QW) SC doses of MET-097i across various dose levels (0.4 mg to 1.2 mg), followed by a single higher-dose administration intended to simulate monthly dosing (2 or 4 the weekly dose)